Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1105-2025Class II

NeiMed NasoGel for DRY NOSES UDI-DI/UPC code: 00705928045309 SKU GSP30-2R-48-ENU-USL GSP30-0R-96-ENU-USL...

Neilmed Pharmaceuticals Inc / initiated 2024-12-28 / Open, Classified / root cause: sterility

Neilmed Pharmaceuticals Inc began a recall of NeiMed NasoGel for DRY NOSES UDI-DI/UPC code: 00705928045309 SKU GSP30-2R-48-ENU-USL GSP30-0R-96-ENU-USL GSP30-ARA-INTL GSP30-SWE-INTL GSP30-ENG-INT... on . FDA classified it as Class II and gives the reason as "Due to nasal spray stability failure for bioburden". As of , the recall status on record is Open, Classified, and MDM tags the root cause as sterility.

Recall record

Recall number
Z-1105-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Neilmed Pharmaceuticals Inc
Product
NeiMed NasoGel for DRY NOSES UDI-DI/UPC code: 00705928045309 SKU GSP30-2R-48-ENU-USL GSP30-0R-96-ENU-USL GSP30-ARA-INTL GSP30-SWE-INTL GSP30-ENG-INT GSP30-MAL-INTL GSP30-SPA-INT NasoGel Spray is a saline-based gel formula that can be sprayed to moisturize and lubricate dry and irritated anterior or front of nasal passages caused by dry climate and indoor heat.
Product code
KCJ Applicator, Ent
Reason for recall
Due to nasal spray stability failure for bioburden.
Root cause tag
sterility
FDA root cause
Under Investigation by firm
Action
On 12/28/2024, the firm sent an "URGENT: MEDICAL DEVICE RECALL" Letter to customers informing them that firm is conduct a voluntary recall due to a microbial failure found during routine stability testing and the receipt of complaints (11 reports) related to the products unpleasant odor. Through investigation, this has led to the recall of 3 lots. We started shipping these lots in April 2024. Customer are instructed to: Immediately examine their inventory and quarantine products subject to recall and destroy the identified lots. In addition, if the affected products have been further distributed, please identify the consumers and notify them at once of this product recall. A copy of this recall notification letter may enhance your notification to your consumers. The firm will provide customers with a refund or product replacement at no cost. Please send us the proof of destruction via email to [email protected]. For any questions, contact Dinesh Patel. M F, 8:00 am - 5:00 pm PST, (707) 889-4625. On or about 02/06/2025, the firm added a Recall Statement to it company website https://shop.neilmed.com/products/nasogel-spray that reads "Recall Notice: NeilMed is voluntarily recalling NasoGel Spray lots NGS751, NGS757, and NGS762 distributed in 2024 due to potential contamination, which may lead to symptoms similar to the flu. If your product is affected, please email [email protected] and put NGS-PA in the subject for further instructions .
Quantity in commerce
89,312
Distribution
Worldwide - U.S. Nationwide distribution in the states of AL, AZ, CA, CO, CT, FL, GA, ID, IL, IN, KY, MA, MD, MI, MN, MO, NC, NJ, NM, NY, OH, OR, PA, RI, SC, TN, TX, VA, VT, WA, and WI. The countries of Bahrain, Ireland, Malaysia, Mexico, and United Kingdom.
Product codes and lots
NasoGel Spray UDI-DI/UPC code: 00705928045309 SKU / Lot Numbers: GSP30-2R-48-ENU-USL / NGS751 GSP30-0R-96-ENU-USL / NGS757 and NGS762 GSP30-ARA-INTL / NGS762 GSP30-SWE-INTL / NGS754 GSP30-ENG-INT / NGS755 GSP30-MAL-INTL / NGS756 GSP30-SPA-INT / NGS760 and NGS761

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1105-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1105-2025Class IIOngoingVoluntary: Firm initiated